What is it about?
Wharton’s jelly (umbilical cord matrix) is promising source of pluripotent stem cells that can differentiate to cardiomyocytes, and drive functional myocardial regeneration. We show in high cell uptake administered one hour after administratio to an infarct-related artery. No clinical symptoms or ECG signs of myocardial ischaemia occurred with cell delivery
Featured Image
Photo by Paweł Czerwiński on Unsplash
Why is it important?
Wharton's Jelly Plurioptent Stem Cells can be safely administered to infarct-related artery 5-7 days after myocardial infarction. High cell uptake makes regenerative therapy promising.
Perspectives
Use of Wharton's Jelly Plurioptent Stem Cells is a novel myocardial regeneration strategy Wharton’s jelly is unlimited source of non-immunogenic cells,
Leszek Drabik
Uniwersytet Jagiellonski w Krakowie
Read the Original
This page is a summary of: P4027Safety and high-grade myocardial uptake of Whartons Jelly Plurioptent Stem Cells transcoronary transfer in acute myocardial infarction in man, European Heart Journal, August 2017, Oxford University Press (OUP),
DOI: 10.1093/eurheartj/ehx504.p4027.
You can read the full text:
Resources
Contributors
The following have contributed to this page
